Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether the use of fibrin glue during nasal surgery leads to a shorter recovery period with less bruising and/or swelling.


Clinical Trial Description

Septorhinoplasty is a well established technique to correct nasal deformity. Drawbacks of this procedure include a significant recovery following surgery which may often require nasal taping and casting. Swelling and bruising in and around the surgical site may persist for months after the operation. At present, there is no standard regarding the length of time nasal tape and cast should be used following septorhinoplasty. It has never been proven that taping or casting is required - in surgeries that require minimal amounts of tissue handling, we may not use any tape or cast following the procedure. Homologous fibrin glue has been used for various cosmetic facial plastic procedures since the early 1980's. It has been shown to decrease bruising and swelling following surgery. This study is being undertaken to evaluate these benefits of using fibrin glue in nasal surgery. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00713596
Study type Interventional
Source Mayo Clinic
Contact
Status Terminated
Phase N/A
Start date July 2008
Completion date January 2010

See also
  Status Clinical Trial Phase
Completed NCT04758728 - Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping N/A
Completed NCT00940446 - A Comparison of INSORB Staples With Metal Staples in Total Hip Replacement N/A
Completed NCT05771285 - Cold Application on the Subcutaneous Injection N/A
Terminated NCT01645774 - Comparing Pain and Bruising of Subcutaneous Heparin Injection Phase 2/Phase 3
Recruiting NCT04724772 - Use of Tranexamic Acid in Blepharoplasties Phase 3